During the past decade, Hospital Valle Hebrón-Materno Infantil conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Valle Hebrón-Materno Infantil" are "Acute Lymphoblastic Leukemia" (4 trials), "Acute Myeloblastic Leukemia" (1 trials), "Cromosome Philadelphia Positive" (1 trials), "LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES" (1 trials) and "Microdeletion Syndromes" (1 trials). Many other conditions were trialed in "Hospital Valle Hebrón-Materno Infantil" in a lesser frequency.

Most popular intervention types in "Hospital Valle Hebrón-Materno Infantil" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Daunorubicin" (3 trials), "Methotrexate" (3 trials), "Vincristine" (3 trials) and "chemotherapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Valle Hebrón-Materno Infantil" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Valle Hebrón-Materno Infantil". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Valle Hebrón-Materno Infantil, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Valle Hebrón-Materno Infantil, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".